title: Low acetate concentrations favor polyphosphate-accumulating organisms over glycogen-accumulating organisms in enhanced biological phosphorus removal from wastewater.
abstract: Glycogen-accumulating organisms (GAOs) are thought to compete with polyphosphate-accumulating organisms (PAOs) in enhanced biological phosphorus removal (EBPR) wastewater treatment systems. A laboratory sequencing batch reactor (SBR) was operated for one year to test the hypothesis that PAOs have a competitive advantage at low acetate concentrations, with a focus on low pH conditions previously shown to favor GAOs. PAOs dominated the system under conventional SBR operation with rapid acetate addition (producing high in-reactor concentrations) and pH values of 7.4-8.4. GAOs dominated when the pH was decreased (6.4-7.0). Decreasing the acetate addition rate led to very low reactor acetate concentrations, and PAOs recovered, supporting the study hypothesis. When the acetate feed rate was increased, EBPR failed again. Dominant PAOs and GAOs were Candidatus Accumulibacter phosphatis and Defluviicoccus Cluster 2, respectively, according to fluorescent in situ hybridization and 454 pyrosequencing. Surprisingly, GAOs were not the immediate causes of PAO failures, based on functional and population measurements. Pyrosequencing results suggested Dechloromonas and Tetrasphaera spp. may have also been PAOs, and additional potential GAOs were also identified. Full-scale systems typically have lower in-reactor acetate concentrations than laboratory SBRs, and so, previous laboratory studies may have overestimated the practical importance of GAOs as causes of EBPR failure.
authors.affiliation: Department of Civil Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States.
authors.forename: Yunjie
authors.initials: Y
authors.lastname: Tu
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Schuler
mesh_terms: D000085:Acetates / Q000494:pharmacology*; D000332:Aerobiosis / Q000187:drug effects; D000693:Anaerobiosis / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects / Q000378:metabolism*; D001673:Biodegradation, Environmental / Q000187:drug effects; D019149:Bioreactors / Q000382:microbiology; D006003:Glycogen / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D017404:In Situ Hybridization, Fluorescence; D010758:Phosphorus / Q000302:isolation & purification*; D011122:Polyphosphates / Q000378:metabolism*; D017422:Sequence Analysis, DNA; D062065:Wastewater / Q000382:microbiology*
chemical_list: D000085:Acetates; D006003:Glycogen; D010758:Phosphorus; D011122:Polyphosphates; D062065:Wastewater